Dotimas, Kent John S.
HRN: 12-94-87 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/14/2022
CEFTRIAXONE 1G (VIAL)
09/14/2022
09/20/2022
IVT
2g
Od
Uti; T/c Acute AP
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes